This is why a direct-to-consumer medical device company is a risky undertaking https://t.co/zQbT35kQ84
— The Propell Group (@ThePropellGroup) April 21, 2017
#healthtech
This is why a direct-to-consumer medical device company is a risky undertaking https://t.co/zQbT35kQ84
— The Propell Group (@ThePropellGroup) April 21, 2017
#healthtech